Is NF-κB a useful therapeutic target in rheumatoid arthritis?

Annals of the Rheumatic Diseases

Volumn 61, Issue SUPPL. 2, 2002, Pages

  Feldmann, M ^a   Andreakos, E ^a   Smith, C ^a   Bondeson, J ^a   Yoshimura, S ^a   Kiriakidis, S ^a   Monaco, C ^a   Gasparini, C ^a   Sacre, S ^a   Lundberg, A ^a   Paleolog, E ^a   Horwood, N J ^a   Brennan, F M ^a   Foxwell, B M J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TREATMENT PLANNING; ADENOVIRUS; ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CULTURE TECHNIQUE; DENDRITIC CELL; DRUG ANTAGONISM; GENE VECTOR; GENETICS; IMMUNOLOGY; MIXED LYMPHOCYTE CULTURE; PHYSIOLOGY; REVIEW;

ADENOVIRIDAE; ANTIGEN PRESENTATION; ARTHRITIS, RHEUMATOID; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; GENETIC VECTORS; HUMANS; I-KAPPA B PROTEINS; IMMUNITY, CELLULAR; LYMPHOCYTE CULTURE TEST, MIXED; NF-KAPPA B; SYNOVIAL MEMBRANE;

EID: 0036839571     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60.
2. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-kappa B activity. Annu Rev Immunol 2000;18:621-63.
3. Handel ML, McMorrow LB, Gravallese EM. Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum 1995;38:1762-70.
4. Marok R, Winyard PG, Coumbe A, Kus ML, Gaffney K, Blades S, et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583-91.
5. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3:207-20.
6. Foxwell B, Browne K, Bondeson J, Clarke C, de Martin R, Brennan F, et al. Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent. Proc Natl Acad Sci USA 1998;95:8211-15.
7. Foxwell BM, Yoshimura S, Bondeson J, Brennan FM, Feldmann M. High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach. Ann Rheum Dis 2001;60(suppl 111):iii13-17.
8. Smith C, Andreakos E, Crawley JB, Brennan FM, Feldmann M, Foxwell BM. NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. J Immunol 2001;167:5895-903
9. Ciesielski CJ, Andreakos E, Foxwell BM, Feldmann M. TNF-induced macrophage chemokine secretion is more dependent on NF-κB expression than lipopolysaccharides-induced macrophage chemokine secretion. Eur J Immunol 2002;32:2037-45.
10. Bondeson J, Foxwell B, Brennan F, Feldmann M. Defining therapeutic targets by using adenovirus: Blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 1999;96:5668-73.
11. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 1986;47:921-8.
12. Yoshimura S, Bondeson J, Foxwell BM, Brennan FM, Feldmann M. Effective antigen presentation by dendritic cells is NF-kappaB dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 2001;13:675-83.
13. Yoshimura S, Bondeson J, Brennan FM, Foxwell BM, Feldmann M. Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Effective antigen presentation by dendritic cells is NF-kappaB dependent: Coordinate regulation of MHC, co-stimulatory molecules and cytokines. Eur J Immunol 2001;31:1883-93
14. Miagkov AV, Kovalenko DV, Brown CE, Didsbury JR, Cogswell JP, Stimpson SA, et al. NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA 1998;95:13859-64.
15. Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, et al. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 1999;42:2532-42.
16. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. Science 1997;278:866-9.
17. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 1997;388:548-54.
18. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52.
19. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, et al. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997;278:860-6.
20. Oitzinger W, Hofer-Warbinek R, Schmid JA, Koshelnick Y, Binder BR, de Martin R. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood 2001;97:1611-17.
21. Conron M, Andreakos E, Pantelidis P, Smith C, Beynon HLC, duBois RM, et al. NF-κB activation in alveolar macrophages requires IκB kinase 2, but not NF-κB inducing kinase. Am J Respir Crit Care Med 2002;165:996-1004.
22. Thomas R, Lipsky PE. Antigen-presenting cells in rheumatoid arthritis. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Springer Semin Immunopathol 1998;20:53-72.
23. Thomas R, Lipsky PE. Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis? Immunol Today 1996;17:559-56.